Patent details
EP2783686 Title: Combination of a rapamycin derivative and letrozole for treating breast cancer
Basic Information
- Publication number:
- EP2783686
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP141642595
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Combination of a rapamycin derivative and letrozole for treating breast cancer
- French Title of Invention:
- Association d'un dérivé de rapamycine et de létrozole pour le traitement du cancer du sein
- German Title of Invention:
- Kombination aus einem Rapamycin Derivat und Letrozol zur Behandlung von Brustkrebs
- SPC Number:
Dates
- Filing date:
- 18/02/2002
- Grant date:
- 21/06/2017
- EP Publication Date:
- 01/10/2014
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/06/2017
- EP B1 Publication Date:
- 21/06/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 18/02/2018
- Expiration date:
- 18/02/2022
- Renunciation date:
- Revocation date:
- 30/08/2018
- Annulment date:
Owner
- From:
- 13/03/2019
- Name:
- NOVARTIS INTERNATIONAL PHARMACEUTICAL AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
- Name:
- NOVARTIS PHARMA AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
History of Owners
- From:
- 21/06/2017
- To:
- 13/03/2019
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- O'Reilly, Terence
- Address:
- Switzerland (CH)
2
- Name:
- Lane, Heidi
- Address:
- Switzerland (CH)
3
- Name:
- Wood, Jeanette Marjorie
- Address:
- Switzerland (CH)
Licencee
- Name:
- N.V. Novartis Pharma S.A.
- From:
- 27/03/2019
- Address:
- Medialaan 40, 1800, Vilvoorde, Belgium (BE)
- To:
Priority
1
- Priority Number:
- 0104072
- Priority Date:
- 19/02/2001
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 0124957
- Priority Date:
- 17/10/2001
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
- A61K 31/337; A61K 31/4196; A61K 31/436; A61K 31/502; A61K 31/704; A61K 31/7068; A61K 33/24; A61P 35/00;
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2019/05
- Publication date:
- 11/04/2019
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
2
- Bulletin Heading:
- MED
- Bulletin edition number:
- 2019/06
- Publication date:
- 06/05/2019
- Description:
- Section K : Modifications and recordals into the register
European Patent Bulletin
1
- Issue number:
- 201725
- Publication date:
- 21/06/2017
- Description:
- Grant (B1)
2
- Issue number:
- 201817
- Publication date:
- 25/04/2018
- Description:
- Opposition procedure started
3
- Issue number:
- 201901
- Publication date:
- 02/01/2019
- Description:
- Revocation of the European patent
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20190000121A
- Date Registered:
- 13/03/2019
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
1
- Name:
- NOVARTIS PHARMA AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
2
- Name:
- NOVARTIS INTERNATIONAL PHARMACEUTICAL AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Removed Pledgee
- Name:
- Address:
Licence
- Change Kind/ Decision Type:
- New licence registration
- Deed Number:
- RC20190000141A
- Date Registered:
- 27/03/2019
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Not Exclusive
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Luxembourg (LU)
- Updated Licence Number:
- Terminated Licence Number:
Added Licencee(s)
- Name:
- N.V. Novartis Pharma S.A.
- Address:
- Medialaan 40, 1800, Vilvoorde, Belgium (BE)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 01/04/2019 | Outgoing Correspondence | 1 |
| 21/03/2019 | Outgoing Correspondence | 2 |
| 27/03/2019 | Request For Change | 6 |
| 13/03/2019 | Request For Change | 6 |